Cell and Gene Manufacturing and Logistics

  1. mAb Aggregate Control On-Demand Webinar 5/22/2026

    Aggregation can undermine yield and quality in downstream mAb processing. Learn practical capture, polishing, and TFF strategies to prevent and reduce aggregates, with a focus on chromatography.

  2. Increase Cell Culture Yield Without Increasing Aggregation 5/22/2026

    Designed for CHO cell culture processes, the HyClone™ glycan supplement enhances galactosylation and maintains stable culture performance.

  3. Keeping mAb Aggregation Low During The Final UF/DF Step 5/22/2026

    mAb aggregation can arise from molecular properties, process conditions, and equipment‑driven stress. Learn where aggregation risk increases across downstream processing and formulation.

  4. Controlling mAb Aggregates In Chromatography Process Development 5/22/2026

    Antibody aggregation remains a critical downstream challenge, particularly for complex modalities. Explore why aggregates form, why they matter, and how chromatographic strategies can help reduce risk.

  5. Field Notes: Freeing Process Data For Automation At Kivi Bio AI Summit 5/22/2026

    The missing link between data generation and unleashing it to power automation often lies in well-governed cloud infrastructure.

  6. Advancing Therapeutic Discovery With High-Throughput Electroporation 5/21/2026

    Learn how high-throughput electroporation streamlines genetic material delivery for cell therapy and drug discovery, offering speed, precision, and scalability across hard-to-transfect cell types.

  7. CGT Manufacturing Shifts From Capacity To Strategy 5/21/2026

    As manufacturing overcapacity reshapes the CGT landscape, success now depends less on access to capacity and more on strategic alignment across development, regulatory readiness, and long-term commercialization.

  8. Increasing Patient Safety: Risk Assessment For Small Volume Fluid Management 5/20/2026

    Explore the risk factors in small-volume fluid management, learn where manual processes introduce variability, and find out how closed, pump-driven single-use systems can improve accuracy and consistency.

  9. Fluid Management In HPAPI Manufacturing 5/20/2026

    Discover how closed-system approaches in HPAPI and ADC manufacturing reduce operator exposure, support Annex 1 alignment, and deliver labor savings of up to 90%.

  10. Making Distributed Manufacturing Work Beyond Theory 5/19/2026

    In this segment of During Cell & Gene Live, “Distributed Manufacturing for CGT: Rent, Lease, or Buy in an Era of Overcapacity?,” experts Emily Moran, Founder, 3LB Consulting, LLC and Sugu Patro, Ph.D., Senior Vice President Global Process Development at Kite, a Gilead Company explored the operational realities behind distributed manufacturing in cell and gene therapy, stating that success depends less on the concept itself and more on orchestration, harmonization, and centralized process control across sites.